By: Marcus J. Hopkins, Blogger
The America Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) have released updated Hepatitis C (HCV) guidance for the “…rapid formulation and dissemination of evidence-based, expert-developed recommendations for Hepatitis C management” (HCV Guidelines [dot] Org, 2017).
The web-based portal was developed over the past few years by ASSLD and IDSA in an effort to address management issues ranging from testing and linkage to care to the optional treatment regimens in particular patient situations (HCV Guidelines). The latest recommendation updates include:
- One-Time HCV Testing protocol recommendations that include testing for those with risk factors such as Injection Drug Use, Intranasal Drug Use, Users of Long-Term Hemodialysis, et cetera
- Annual HCV Testing protocol recommendations for People Who Inject Drugs (PWIDs) and HIV-Positive Men who have Sex with Men (MSM)
- Initial HCV Testing and Follow-Up recommendations that include initial antibody testing, HCV-RNA testing, HCV-RNA testing for those who are risk of reinfection after clearing, Quantitative HCV-RNA testing prior to initial antiviral therapy to determine baseline level of viremia, HCV genotype testing, and notification of no evidence of currently active HCV infection
- Counseling recommendations for people who test positive for HCV
- Recommendations that all people who test positive for HCV be linked to a clinician for comprehensive management (HCV Guidelines, 2018)
In addition to those testing updates, guidance is also provided for unique populations, including HIV/HCV co-infected populations, those with decompensated cirrhosis of the liver, patients who develop recurrent HCV infection after liver transplantation, renal impairment, pregnancy, pediatric patients, et cetera. These recommendations are vital for allowing providers to know how best to treat their patients, particularly in areas of the world where several comorbidities tend to exist.
The new guidelines also include guidance for the testing and treatment of HCV in correctional settings, a drum which HEAL Blog and the Community Access National Network in general has been banging for several years, now. These patients, in particular, are going to be a key population in the fight to end HCV and Viral Hepatitis, in general.
The latest guidelines can be found at the following website: https://www.hcvguidelines.org/.
- HCV Guidelines. (2017, September 21). Introduction. American Association for the Study of Liver Diseases: Infectious Diseases Society of America. Retrieved from: https://www.hcvguidelines.org/contents/welcome
- HCV Guidelines. (2018, May 24). HCV Testing and Linkage to Care. American Association for the Study of Liver Diseases: Infectious Diseases Society of America. Retrieved from: https://www.hcvguidelines.org/evaluate/testing-and-linkage
Disclaimer: HEAL Blogs do not necessarily reflect the views of the Community Access National Network (CANN), but rather they provide a neutral platform whereby the author serves to promote open, honest discussion about Hepatitis-related issues and updates. Please note that the content of some of the HEAL Blogs might be graphic due to the nature of the issues being addressed in it.